Integrated network pharmacology reveal new key curcumin-binding targets in triple-negative breast cancer
Xiaohang Qi, Hua Zhang, Shucong Wang, Lu Qiao, Li Ma, Kanghuai Zhang, Yan Wang · 2026
Read Integrated network pharmacology reveal new key curcumin-binding targets in triple-negative breast cancer by Xiaohang Qi, Hua Zhang, Shucong Wang, Lu Qiao, Li Ma, Kanghuai Zhang, Yan Wang (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13522272.txt.
Description
Xiaohang Qi and colleagues hunt in 2026 for key protein targets of curcumin in triple-negative breast cancer. Curcumin is a turmeric compound. This cancer type lacks targeted drugs and acts with force. Network maths overlapped curcumin-linked proteins with disease-linked proteins.
Three targets passed the overlap test. Jobs cover cell division checks, growth signals and DNA damage checks. Docking runs showed good binding, on par with known blockers. Long motion simulations showed stable pairs. Energy maths favoured the checkpoint protein most. All proof is by computer only. Cell and animal checks must come before any care claims can stand.
Catalog record
| CREATOR | Xiaohang Qi, Hua Zhang, Shucong Wang, Lu Qiao, Li Ma, Kanghuai Zhang, Yan Wang |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 53511 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |